Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
International Journal of Medicinal Mushrooms
IF: 1.423 5-Year IF: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Print: 1521-9437
ISSN Online: 1940-4344

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.v1.i1.20
pages 9-29

The Extraction and Development of Antitumor-Active Polysaccharides from Medicinal Mushrooms in Japan (Review)

Takashi Mizuno
Department of Applied Biological Chemistry, Faculty of Agriculture, Shizuoka University, 4-13-9 Seinan-Cho, Fujieda-Shi 426-0063, Japan

ABSTRACT

It has been known for many years that most mushrooms with known effects against cancer belong to the family Polyporaceae s.l. (Agaricales s.l.). However, the components responsible for such action have not been clearly defined. In Japan, in 1968, a hot water extract from some edible mushrooms belonging to the family Polyporaceae s.l., showed a marked host-mediated antitumor activity. Since then, numerous researchers have isolated active polysaccharides and have identified them to be (1→3)-β-D-glucopyranans with a (1→6)-β-D-glucosyl branch containing protein. Several antitumor polysaccharides, some hetero-β-glucans and their protein complexes, such as xyloglucans and acidic β-glucan containing uronic acid, are insoluble in water. They were, however, isolated from the extracts using large amounts of dilute alkali with Japanese (8 species) and Chinese (5 species) mushrooms. Several trials have been made to enhance activity by chemical modification, such as polyalcohols formed by a mild Smith degradation and the products formed by BH4-reduction after 104-oxidation. Mushroom polysaccharides are considered to be biological response modifiers (BRM), or immunopotentiators, because of their action mechanism. In Japan, three different polysaccharide antitumor agents have been developed from the fruit body, mycelium, and cultured medium, of three mushroom species.


Articles with similar content:

A Review of Pharmacological Activities of Mushroom Polysaccharides
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 3
Vincent Eng Choo Ooi, Fang Liu
Bioactive Substances in Hericium erinaceus (Bull.: Fr.) Pers. (Yamabushitake), and Its Medicinal Utilization
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 2
Takashi Mizuno
Comparison of the Immunomodulating Activities of 1,3-β-glucan Fractions from the Culinary-Medicinal Mushroom Sparassis crispa Wulf.:Fr. (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.8, 2006, issue 3
Yoshiyuki Adachi, Noriko N. Miura, Hiromi Kawaminami, Toshiro Yadomae, Mitsuhiro Nakajima, Naohito Ohno, Toshie Harada
Structural Characteristics of the Novel Polysaccharide FVPA1 from Winter Culinary-Medicinal Mushroom, Flammulina velutipes (Agaricomycetes), Capable of Enhancing Natural Killer Cell Activity against K562 Tumor Cells
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 6
Hong-Ge Chen, Jing-Song Zhang, Chi-Chung Lin, Wei Jia, Wenhan Wang, Jie Feng
Hepatoprotective Activity and the Mechanisms of Action of Ganoderma lucidum (Curt.:Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) (Aphyllophoromycetideae) (Review)
International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 2
Yihuai Gao, Min Huang, Zhi-Bin Lin, Shufeng Zhou